Ein Mann liest Wirtschaftsnachrichten (Symbolbild).
Montag, 08.05.2023 09:00 von | Aufrufe: 64

TMX Group Equity Financing Statistics - April 2023

Ein Mann liest Wirtschaftsnachrichten (Symbolbild). pixabay.com

Canada NewsWire

Toronto Stock Exchange, TSX Venture Exchange

TORONTO, May 8, 2023 /CNW/ - TMX Group today announced its financing activity on Toronto Stock Exchange (TSX) and TSX Venture Exchange (TSXV) for April 2023.

TSX welcomed nine new issuers in April 2023, compared with two in the previous month and six in April 2022. The new listings were all exchange traded funds. Total financings raised in April 2023 decreased 51% compared to the previous month, and were down 59% compared to April 2022. The total number of financings in April 2023 was 21, compared with 30 the previous month and 36 in April 2022.

For additional data relating to the number of transactions billed for TSX, please click on the following link: https://www.tmx.com/resource/en/440 

TSXV welcomed three new issuers in April 2023, compared with seven in the previous month and 15 in April 2022. The new listings were one Capital Pool Company, one consumer products company and one mining company. Total financings raised in April 2023 decreased 1% compared to the previous month, and were down 58% compared to April 2022. There were 77 financings in April 2023, compared with 106 in the previous month and 131 in April 2022.

TMX Group consolidated trading statistics for April 2023 can be viewed at www.tmx.com.

Toronto Stock Exchange


ARIVA.DE Börsen-Geflüster


April 2023

March 2023

April 2022

Issuers Listed                                                

1,788

1,798

1,775

New Issuers Listed

9

2

6

IPOs                                                                

9

1

2

Graduates from TSXV

0

1

3

Issues Listed                                                  

2,460

2,475

2,467

IPO Financings Raised                                  

$82,812,133

$150,008,000

$144,635,000

Secondary Financings Raised

$124,106,309

$815,693,092

$927,517,186

Supplemental Financings Raised

$348,789,810

$166,000,000

$296,714,517

Total Financings Raised

$555,708,252

$1,131,701,092

$1,368,866,703

Total Number of Financings                        

21

30

36

Market Cap Listed Issues                            

$4,091,870,982,904

$4,021,633,630,681

$4,137,719,353,036

 

Year-to-date Statistics


2023

2022

% change

New Issuers Listed                                       

40

50

-20.0

IPOs

35

36

-2.8

Graduates from TSXV

4

9

-55.6

IPO Financings Raised                                  

$342,831,174

$492,858,297

-30.4

Secondary Financings Raised

$1,543,831,306

$7,137,489,370

-78.4

Supplemental Financings Raised

$616,289,810

$1,587,635,200

-61.2

Total Financings Raised

$2,502,952,290

$9,217,982,867

-72.8

Total Number of Financings

125

191

-34.6

Market Cap Listed Issues

$4,091,870,982,904

$4,137,719,353,036

-1.1

 

TSX Venture Exchange**


April 2023

Werbung

Mehr Nachrichten zur Hemispherx Biopharma Aktie kostenlos abonnieren

E-Mail-Adresse
Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.


Andere Nutzer interessierten sich auch für folgende News